Contact this trialFirst, we need to learn more about you.
Virus Therapy
RP1 for Advanced Skin Cancer in Transplant Patients
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial is investigating whether a new drug is effective and safe for people with advanced skin cancer who have had organ transplants. Up to 65 people will be enrolled, and the trial will last for 3 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.